Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families

European Journal of Human Genetics

Volumn 7, Issue 3, 1999, Pages 377-385

  D'Alfonso, Sandra ^a   Nisticò, Lorenza ^b   Zavattari, Patrizia ^a   Marrosu, Maria Giovanna ^f   Murru, Raffaele ^f   Lai, Marina ^f   Massacesi, Luca ^f   Ballerini, Clara ^f   Gestri, Donella ^f   Salvetti, Marco ^c   Ristori, Giovanni ^c   Bomprezzi, Roberto ^c   Trojano, Maria ^f   Liguori, Maria ^f   Gambi, Domenico ^d   Quattrone, Aldo ^f   Fruci, Doriana ^b   Cucca, Francesco ^f   Richiardi, Patricia Momigliano ^a   Tosi, Roberto ^b,e  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e Istituto di Biologia Cellulare   (Italy)

^f NONE

Author keywords

Linkage analysis; Multiple sclerosis; Multiplex families

Indexed keywords

APOLIPOPROTEIN E; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; INTERLEUKIN 9; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CHROMOSOME 22Q; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 7P; COMPUTER PROGRAM; FLUORESCENCE; GENETIC LINKAGE; GENETIC MARKER; HUMAN; HUMAN CELL; ITALY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POPULATION GENETICS; PRIORITY JOURNAL;

GENETIC MARKERS; HUMANS; ITALY; LINKAGE (GENETICS); MULTIPLE SCLEROSIS;

EID: 0032961268     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200301     Document Type: Article

References (39)

1. Poser CM: The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994; 36 (S2): S180-S193.
2. Reder AT, Arnason BGV: Immunology of multiple sclerosis. In: Vinken PJ. Bruyn GW, Klawans HC (eds). Handbook of Clinical Neurology. Elsevier Science: Amsterdam, 1985, vol. 47, pp 337-396.
3. Martin R, McFarland H, McFarlin D: Immunological aspects of demyelinating disease. Annu Rev Immunol 1992; 10: 153-187.
4. Hohlfeld R, Londei M, Massacesi L, Salvetti M: T-cell autoimmunity in multiple sclerosis. Immunology Today 1995; 16: 259-261.
5. Kurtzke JF: MS epidemiology world wide. One view of current status. Acta Neurol Scand 1995; S161: 23-33.
6. Ebers GC, Sadovnick AD: The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993; 12: 1-5.
7. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DAS: Age-adjusted recurrence risks for relatives of patients with MS. Brain 1996; 119: 449-455.
8. Ebers GC, Sadovnick AD, Risch NJ and the Canadian Collaborative Study Group: Familial aggregation in MS is genetic. Nature 1995; 377: 150-151.
9. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ and the Canadian Collaborative Study Group: Evidence for genetic basis of MS. Lancet 1996; 347: 1728-1730.
10. Dyment DA, Sadnovich AD, Ebers GC: Genetics of MS. Hum Mol Genet 1997; 6: 1693-1698.
11. Kuokkanen S, Gschwend M, Rioux JD et al: Genomewide scan of MS in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-1387.
12. Lander ES, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
13. Sundvall M, Jirholt J, Yang HT et al: Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 1995; 10: 313-317.
14. Roth MP, Viratelle C, Dolbois L et al: Genome wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J Immunol in press.
15. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
16. Nisticò L, Buzzetti R, Pritchard LE et al: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996; 5: 1075-1080.
17. Marron MP, Raffel LJ, Garchon HJ et al: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA-4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997; 6: 1275-1282.
18. Piazza A, Mayr WR, Contu L et al: Genetic and population structure of four Sardinian villages. Ann Hum Genet 1985; 49: 47-63.
19. Granieri E, Casetta I, Tola MR: Epidemiology of MS in Italy and in Southern Europe. Acta Neurol Scand 1995; S161: 60-70.
20. Rosati G, Aiello I, Pirastu MI et al: Epidemiology of MS in north-western Sardinia: further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996; 15: 10-19.
21. Kotsa K, Watson PF, Weetman AP: A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol 1997; 46: 551-554.
22. Poser CM, Paty DW, Scheinberg L: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
23. Dib C, Faure S, Fizames C et al. A comprehensive genetic map of the human genoma based on 5264 microsatellites. Nature 1966; 380: 152-154.
24. Murray JC, Buetow KH, Weber JL et al. A comprehensive human linkage map with centimorgan density: Cooperative Human Linkage Center (CHLC). Science 1994; 265: 2049-2054.
25. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES: Parametric and non parametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-1363.
26. Collins A, Frezal J, Teague J, Morton NE: A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci USA 1996; 93: 14771-14775; (http://cedar.genetics.soton.ac.uk/ publ.ic - html/gmap.html).
27. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
28. Davis S, Schroeder M, Goldin LR, Weeks DE: Non-parametric simulation-based statistics for detecting linkage in general pedigrees. Am J Hum Genet 1996; 58: 867-880.
29. Davis S, Goldin LR, Weeks DE: SimIBD: A powerful robust non parametric method for detecting linkage in general pedigrees. In: Pawlowitzki I-H, Edwards JH, Thompson EA (eds). Genetic Mapping of Disease Genes. Academic Press: San Diego, CA, 1997, pp 189-204.
30. Haines JL for The Multiple Sclerosis Genetics Group: A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996; 13: 469-471.
31. Sawcer S, Jones HB, Feakes R et al: A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13: 464-468.
32. Ebers GC, Kukay K, Bulman DE et al: A full genome screen in multiple sclerosis. Nat Genet 1996; 13: 472-476.
33. Kuokkanen S, Sundvall M, Terwilliger JD et al: A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet 1996; 13: 477-480.
34. Marrosu MG, Murru MR, Costa G et al: Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 1997; 61: 454-457.
35. Risch N: Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40: 1-14.
36. Todd JA: Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 1995; 92: 8560-8565.
37. Haines JL, Terwedow HA, Burgess K et al: Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 1998; 7: 1229-1234.
38. Roses AD, Devlin D, Conneally PM et al. Measuring the genetic contribution of ApoE in late-onset Alzheimer disease. Am J Hum Genet 1995; 57: (suppl.): A202.
39. Becker KG, Simon RM, Bailey-Wilson JE et al: Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95: 9979-9984.